Pre-Hospital Use of Plasma for Traumatic Hemorrhage

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE2/PHASE3

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Type A Thawed Plasma (TP) will be compared in polytrauma patients who receive only Normal Saline (NS) (standard of care) before arrival at the hospital.

The purpose of this study is to determine if prehospital administration of thawed plasma can reduce mortality of patients who have lost a large amount of blood due to their injuries, compared to those receiving standard of care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Control of Major Bleeding After Trauma Study

NCT01838863

Trauma Hemorrhagic Shock

TERMINATED PHASE2

Study Using Plasma for Patients Requiring Emergency Surgery

NCT01221389

Hemorrhagic Shock Blood Coagulation Disorders Blood Products +2 more

WITHDRAWN PHASE4

Pre-hospital Administration of Fibrinogen in Trauma-Induced Coagulopathy

NCT06582420

Trauma Induced Coagulopathy

NOT_YET_RECRUITING NA

Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage

NCT02344069

Trauma Haemorrhage

COMPLETED PHASE2

Trauma Study: Early Warning of Progression Toward Hemodynamic Deterioration After Trauma

NCT04912232

Occult Bleeding Hemorrhage

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

INVESTIGATIONAL PLAN This will be an open-label, non-blinded, randomized clinical trial to investigate mortality (30 days) and morbidity of Type A thawed Plasma (TP) versus NS infusion at earliest contact, administered by Emergency Medical Service (EMS) supervisors to subjects who have sustained severe Polytrauma / Major hemorrhage (PTr / MH). The total study is expected to last 2 years with 210 patients enrolled.

The two EMS agencies involved in the study will each have one EMS supervisor quick-response vehicle (QRV) equipped with an approved, validated refrigeration unit for TP transport. EMS personnel trained in plasma administration and recognition of reactions may administer up to 2 units of TP to subjects approved for study enrollment. Blood samples for coagulation and lipid testing will be drawn prior to TP administration by EMS personnel,and repeated by hospital personnel at 30 minutes, 8 hours, and 24 hours post-injury.

This study is approved for "Exception from Informed Consent" (EFIC). Once the patient has reached VCUMC and has been entered into the VCUMC health care system, the treating team will advise the Study Coordinator (SC) whether or not a subject is able to consent. As the plasma administration will occur in the field prior to arrival to VCUMC, the SC will make every effort possible to obtain consent from the subject or legally authorized representative (LAR) for continued study participation before the next intervention (8 hour blood specimen collection). The attempts to contact the LAR will be documented in detail. If a subject lacks the ability to provide his/her own consent by the end of day 30, the consent signed by the LAR will be the consent document in force at the subject's completion of the study and no further consent will be sought.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shock, Hemorrhagic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Type A Thawed Plasma

Eligible subjects with polytrauma (PT) and major hemorrhage (MH) will be randomized to receive 2 units of thawed Type A plasma in the pre-hospital setting administered by EMS first responders.

An exception from informed consent under 21CFR 50.24 is required since enrollment will occur (for the majority of subjects) before consent can be obtained.

Group Type ACTIVE_COMPARATOR

Plasma

Intervention Type BIOLOGICAL

Type A thawed plasma (up to 2 units) will be administered to polytrauma subjects randomized to plasma arm of study

Normal saline

Eligible subjects with polytrauma (PT) and major hemorrhage (MH) will be randomized to receive normal saline in the pre-hospital setting administered by EMS first responders. Normal saline is standard of care

Group Type PLACEBO_COMPARATOR

Normal saline

Intervention Type DRUG

Normal saline will be administered to polytrauma subjects randomized to normal saline arm of study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Plasma

Type A thawed plasma (up to 2 units) will be administered to polytrauma subjects randomized to plasma arm of study

Intervention Type BIOLOGICAL

Normal saline

Normal saline will be administered to polytrauma subjects randomized to normal saline arm of study

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Thawed Plasma 0.9% Normal Saline

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Blunt or penetrating trauma,
* Blood Pressure (BP) systolic \<70 mmHg or BP 70-90 mmHg with Heart Rate (HR) \> 108 Beats Per Minute (BPM),
* Ongoing hemorrhage with unstable vital signs

Exclusion Criteria

* Wearing opt-out wrist band,
* Wearing medical alert jewelry / bracelet, etc. indicating Jehovah Witness or similar with objections to blood transfusions,
* Refusal to participate (by subject or LAR),
* Communication barrier at the time of eliciting refusal (non-English speaking or non-Spanish speaking),
* Not expected to survive transport to Virginia Commonwealth University Medical Center (VCUMC),
* Documented Do Not Resuscitate (DNR) order found,
* Cardiac arrest or Cardio-Pulmonary Resuscitation (CPR) prior to randomization
* Penetrating head trauma,
* Known / obvious pregnancy,
* Prisoner,
* Burns \> 20% of body surface

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No